{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:11:57Z","timestamp":1767143517301,"version":"build-2238731810"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"AstraZeneca Co., Ltd. and Ono Pharmaceutical Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s13300-018-0555-5","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T21:47:13Z","timestamp":1545342433000},"page":"311-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus"],"prefix":"10.1007","volume":"10","author":[{"given":"Yasuhiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuichi","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigaku","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiji","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Tatsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"issue":"21","key":"555_CR1","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1001\/jama.1978.03290210081040","volume":"240","author":"BR Bistrian","year":"1978","unstructured":"Bistrian BR. Clinical use of a protein-sparing modified fast. JAMA. 1978;240(21):2299\u2013302.","journal-title":"JAMA"},{"issue":"1","key":"555_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3164\/jcbn.2.91","volume":"2","author":"Y Saito","year":"1987","unstructured":"Saito Y, Ishikawa Y, Shinomiya M, Shirai K, Yoshida S. Effects of protein-sparing modified fasting on obese Japanese patients. J Clin Biochem Nutr. 1987;2(1):91\u2013100.","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"555_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/sj.ijo.0802258","volume":"27","author":"SB Heymsfield","year":"2003","unstructured":"Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord. 2003;27(5):537\u201349.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"555_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.ejcn.1601587","volume":"57","author":"DB Allison","year":"2003","unstructured":"Allison DB, Gadbury G, Schwartz LG, et al. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr. 2003;57(4):514\u201322.","journal-title":"Eur J Clin Nutr"},{"issue":"10","key":"555_CR5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ejcn.2009.48","volume":"63","author":"C Vazquez","year":"2009","unstructured":"Vazquez C, Montagna C, Alcaraz F, et al. Meal replacement with a low-calorie diet formula in weight loss maintenance after weight loss induction with diet alone. Eur J Clin Nutr. 2009;63(10):1226\u201332.","journal-title":"Eur J Clin Nutr"},{"issue":"Suppl 2","key":"555_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/jhn.12145","volume":"27","author":"K Kempf","year":"2014","unstructured":"Kempf K, Schloot NC, Gartner B, Keil R, Schadewaldt P, Martin S. Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with\u2009>\u2009100 U insulin per day. J Hum Nutr Diet. 2014;27(Suppl 2):21\u20137.","journal-title":"J Hum Nutr Diet"},{"issue":"11","key":"555_CR7","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/oby.21649","volume":"24","author":"CP Moldovan","year":"2016","unstructured":"Moldovan CP, Weldon AJ, Daher NS, et al. Effects of a meal replacement system alone or in combination with phentermine on weight loss and food cravings. Obesity (Silver Spring). 2016;24(11):2344\u201350.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"555_CR8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3945\/ajcn.117.158543","volume":"106","author":"P Christensen","year":"2017","unstructured":"Christensen P, Henriksen M, Bartels EM, et al. Long-term weight-loss maintenance in obese patients with knee osteoarthritis: a randomized trial. Am J Clin Nutr. 2017;106(3):755\u201363.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"555_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ijo.2016.175","volume":"41","author":"WS Leslie","year":"2017","unstructured":"Leslie WS, Taylor R, Harris L, Lean ME. Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes (Lond). 2017;41(1):96\u2013101.","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"555_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/nu10081022","volume":"10","author":"K Kempf","year":"2018","unstructured":"Kempf K, Rohling M, Niedermeier K, Gartner B, Martin S. Individualized meal replacement therapy improves clinically relevant long-term glycemic control in poorly controlled type 2 diabetes patients. Nutrients. 2018;10(8):1022.","journal-title":"Nutrients"},{"issue":"1","key":"555_CR11","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.orcp.2012.03.002","volume":"7","author":"K Shirai","year":"2013","unstructured":"Shirai K, Saiki A, Oikawa S, et al. The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients\u2013multicenter trial. Obes Res Clin Pract. 2013;7(1):e43\u201354.","journal-title":"Obes Res Clin Pract"},{"issue":"4","key":"555_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2337\/dc08-1863","volume":"32","author":"JF List","year":"2009","unstructured":"List JF, Woo V, Morales E, Tang W, Fiedorek FT. Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes. Diabetes Care. 2009;32(4):650\u20137.","journal-title":"Diabetes Care"},{"issue":"3","key":"555_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1210\/en.2015-1588","volume":"157","author":"A Obata","year":"2016","unstructured":"Obata A, Kubota N, Kubota T, et al. Tofogliflozin improves insulin resistance in skeletal muscle and accelerates lipolysis in adipose tissue in male mice. Endocrinology. 2016;157(3):1029\u201342.","journal-title":"Endocrinology"},{"issue":"3","key":"555_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1210\/jc.2011-2260","volume":"97","author":"J Bolinder","year":"2012","unstructured":"Bolinder J, Ljunggren O, Kullberg J, et al. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab. 2012;97(3):1020\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"555_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/dom.12189","volume":"16","author":"J Bolinder","year":"2014","unstructured":"Bolinder J, Ljunggren O, Johansson L, et al. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2\u00a0years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obes Metab. 2014;16(2):159\u201369.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"555_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI70704","volume":"124","author":"A Merovci","year":"2014","unstructured":"Merovci A, Solis-Herrera C, Daniele G, et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest. 2014;124(2):509\u201314.","journal-title":"J Clin Invest"},{"issue":"2","key":"555_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1172\/JCI72227","volume":"124","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest. 2014;124(2):499\u2013508.","journal-title":"J Clin Invest"},{"issue":"2","key":"555_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ajcn\/86.2.276","volume":"86","author":"EC Westman","year":"2007","unstructured":"Westman EC, Feinman RD, Mavropoulos JC, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86(2):276\u201384.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"555_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5551\/jat.13.101","volume":"13","author":"K Shirai","year":"2006","unstructured":"Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101\u20137.","journal-title":"J Atheroscler Thromb"},{"issue":"11","key":"555_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1291\/hypres.27.851","volume":"27","author":"Y Matsui","year":"2004","unstructured":"Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res. 2004;27(11):851\u20137.","journal-title":"Hypertens Res"},{"issue":"Suppl 1","key":"555_CR21","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/S0753-3322(04)80015-5","volume":"58","author":"T Yambe","year":"2004","unstructured":"Yambe T, Yoshizawa M, Saijo Y, et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother. 2004;58(Suppl 1):S95\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"555_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.5551\/jat.28035","volume":"22","author":"L Gomez-Sanchez","year":"2015","unstructured":"Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, et al. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in Caucasian adults: MARK study. J Atheroscler Thromb. 2015;22(9):901\u201311.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"555_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1253\/circj.71.89","volume":"71","author":"T Kubozono","year":"2007","unstructured":"Kubozono T, Miyata M, Ueyama K, et al. Clinical significance and reproducibility of new arterial distensibility index. Circ J. 2007;71(1):89\u201394.","journal-title":"Circ J"},{"issue":"4","key":"555_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1253\/circj.72.598","volume":"72","author":"K Nakamura","year":"2008","unstructured":"Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J. 2008;72(4):598\u2013604.","journal-title":"Circ J"},{"issue":"5","key":"555_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.5551\/jat.3707","volume":"17","author":"H Noike","year":"2010","unstructured":"Noike H, Nakamura K, Sugiyama Y, et al. Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb. 2010;17(5):517\u201325.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"555_CR26","first-page":"554","volume":"21","author":"J Suzuki","year":"2014","unstructured":"Suzuki J, Kurosu T, Kon T, Tomaru T. Impact of cardiovascular risk factors on progression of arteriosclerosis in younger patients: evaluation by carotid duplex ultrasonography and cardio-ankle vascular index(CAVI). J Atheroscler Thromb. 2014;21(6):554\u201362.","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"555_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5551\/jat.24851","volume":"22","author":"P Dobsak","year":"2015","unstructured":"Dobsak P, Soska V, Sochor O, et al. Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension. J Atheroscler Thromb. 2015;22(3):272\u201383.","journal-title":"J Atheroscler Thromb"},{"issue":"10","key":"555_CR28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1291\/hypres.31.1921","volume":"31","author":"N Satoh","year":"2008","unstructured":"Satoh N, Shimatsu A, Kato Y, et al. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res. 2008;31(10):1921\u201330.","journal-title":"Hypertens Res"},{"issue":"5","key":"555_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5603\/AIT.2014.0061","volume":"46","author":"ML Malbrain","year":"2014","unstructured":"Malbrain ML, Huygh J, Dabrowski W, De Waele JJ, Staelens A, Wauters J. The use of bio-electrical impedance analysis (BIA) to guide fluid management, resuscitation and deresuscitation in critically ill patients: a bench-to-bedside review. Anaesthesiol Intensive Ther. 2014;46(5):381\u201391.","journal-title":"Anaesthesiol Intensive Ther"}],"updated-by":[{"DOI":"10.1007\/s13300-020-00757-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000}}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-018-0555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-018-0555-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-018-0555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:28:18Z","timestamp":1724398098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-018-0555-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1007\/s13300-018-0555-5","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original article, the 6th sentence of the section \ufffd\ufffd\ufffdFD and calorie intake\ufffd\ufffd\ufffd is incorrect. The correct sentence is \ufffd\ufffd\ufffdThe protein component of FD consists of whey protein, casein, and soy protein\ufffd\ufffd\ufffd.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original article, the 6th sentence of the section \ufffd\ufffd\ufffdFD and calorie intake\ufffd\ufffd\ufffd is incorrect. The correct sentence is \ufffd\ufffd\ufffdThe protein component of FD consists of whey protein, casein, and soy protein\ufffd\ufffd\ufffd.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}